ID: ALA2393326

Max Phase: Preclinical

Molecular Formula: C10H7N3

Molecular Weight: 169.19

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N#Cc1ccc2c(N)ccnc2c1

Standard InChI:  InChI=1S/C10H7N3/c11-6-7-1-2-8-9(12)3-4-13-10(8)5-7/h1-5H,(H2,12,13)

Standard InChI Key:  ULOMPSGOQQSFAN-UHFFFAOYSA-N

Associated Targets(non-human)

Ferriprotoporphyrin IX 165 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 169.19Molecular Weight (Monoisotopic): 169.0640AlogP: 1.69#Rotatable Bonds: 0
Polar Surface Area: 62.70Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.98CX LogP: 1.16CX LogD: 1.14
Aromatic Rings: 2Heavy Atoms: 13QED Weighted: 0.65Np Likeness Score: -1.07

References

1. Nsumiwa S, Kuter D, Wittlin S, Chibale K, Egan TJ..  (2013)  Structure-activity relationships for ferriprotoporphyrin IX association and β-hematin inhibition by 4-aminoquinolines using experimental and ab initio methods.,  21  (13): [PMID:23669191] [10.1016/j.bmc.2013.04.040]

Source